Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Quinfamide

An amoebicide of the small dichloroacetamide family, patented in 1976 and described in the literature in 1979: it is used against intestinal amoebiasis caused by Entamoeba histolytica. This family brings together the active ingredient and other impurities.

Did you know?It acts mainly inside the gut, where it immobilises the amoebae in the intestinal lumen; in adults it has also been studied as a single-administration treatment.

QuinfamideGo to the active ingredient →
QuinfamideActive ingredientQuinfamideCat. No. P-Q007-001CAS 62265-68-3

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.